Uría Menéndez and Latham & Watkins advise on Euromed deal

Uría Menéndez and Latham & Watkins were instructed in connection with the €82m sale of herbal extract manufacturer Euromed to The Riverside Company.


Uría Menéndez advised The Riverside Company, while Latham & Watkins advised the seller, Swedish company Meda AB, according to Mergermarket.

The total consideration is €82m in upfront cash for the shares of Euromed, which generates sales of around €40m and an EBITDA margin of around 20 per cent on an annual basis.

One of Euromed’s primary products is the “liver health” supplement Legalon API. 

Ben Cook